Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

Authors: Capucine L. Grandjean, Zacarias Garcia, Fabrice Lemaître, Béatrice Bréart, Philippe Bousso

Published: 2021-02-19

DOI: 10.1126/sciadv.abd6167

Source: Full article


Abstract

The mechanism and limitations of anti-CD20 therapy, a major treatment for B cell lymphomas, were uncovered using in vivo imaging.